2Boelsterli UA, Ho HK, Zhou S, et al. Bioactivation and hepatotoxicity of nitroaromatic drugs [ J ]. Curr Drug Metab, 2006,7 ( 7 ) : 715 -727.
3Navarro V J, Senior JR. Drug-related hepatotoxicity [ J ]. N Engl J Med,2006,354 ( 7 ) :731 - 739.
4Kasper HU, Drebber U, Hirsch i, et al. Morphology of drug induced liver damage [ J ]. Pat hology, 2006,27 ( 3 ) : 175 - 181.
5Bjiomsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease[J]. Hepatology,2005,42(2) :481 -489.
6Yew WW, Leung CC. Antituberculosis drugs and hepatotoxicity [ J ]. Respirology ,2006,11 ( 6 ) :699 - 707.
7Sakurai A, Kurata A, Onishi Y, et al. Prediction of drug-induced intrahepatic cholestasis: in vitro screening and QSAR analysis of drugs inhibiting the human bile salt export pump[J]. Expert Opin Drug Saf,2007,6( 1 ) :71 - 86.
8Le Moli R,Baldeschi L,Saeed P,et al. Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves' ophthalmopathy [ J ]. Thyroid,2007,17 (4) :357 - 362.
